✦ LIBER ✦

PNL9 COST EFFECTIVENESS ANALYSIS OF INTERFERON BETA-1A (AVONEX®) IN PRE-CLINICALLY DEFINITE MULTIPLE SCLEROSIS (CDMS)

✍ Scribed by M Iskedjian; J Walker; T Gray; C Vicente; T Einarson; A Gehshan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PNL12 COST UTILITY ANALYSIS OF INTERFERO

✍ M Iskedjian; J Walker; T Gray; C Vicente; T Einarson; A Gehshan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

Cost-Effectiveness of Interferon Beta-1a

✍ Lisa A. Prosser; Karen M. Kuntz; Amit Bar-Or; Milton C. Weinstein 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

PND8 COST-EFFECTIVENESS AND BUDGET IMPAC

✍ O Espallardo; C Crespo; C Polanco; D Nieves 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Cost-effectiveness of fingolimod versus

✍ Lee, Soyon; Baxter, Daniel C.; Limone, Brendan; Roberts, Matthew S.; Coleman, Cr 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 382 KB

PNR1: COST-EFFECTIVENESS AND COST-UTILIT

✍ E Orlewska; P Mierzejewski; A Czlonkowska 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Cost-Effectiveness Analysis of Interfero

✍ John P. Caloyeras; Bin Zhang; Cheng Wang; Marianne Eriksson; Sten Fredrikson; Ka 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 882 KB